Quercetin: The Definitive Guide

What is quercetin?

Quercetin is a flavonol found naturally in foods including onions, apples, berries and tea. Food quercetin usually occurs as sugar-bound glycosides. Supplements may contain free quercetin aglycone, quercetin dihydrate, isoquercitrin or a phospholipid complex. Those names matter because solubility, intestinal handling and measured blood exposure differ. [1]

Laboratory studies describe antioxidant, inflammatory-signaling and antiviral effects. These mechanisms are useful for forming hypotheses, but they do not prove that an oral product prevents infection, treats allergy, improves exercise performance or clears senescent cells in people. Human evidence is outcome- and formulation-specific.

Typical Quercetin Protocols

There is no established RDA, AI or tolerable upper intake level for quercetin. Study amounts are exposures used in named populations, not universal intake targets.

Titration

No evidence-based self-titration schedule is established.

Timing

Heinz 2010 used two chews on awakening and two between 14:00 and the last meal; Han 2020 used twice-daily dosing with food. Edwards 2007 reports only a daily total in the abstract.

Duration

The cited efficacy trials lasted 28 days or 12 weeks; the dose-escalation safety study lasted seven days.

Stopping

Stop and seek review for allergic symptoms, persistent gastrointestinal effects, unusual bruising or bleeding, symptomatic low blood pressure, or a suspected medicine interaction.

What is quercetin commonly used for?

Products are promoted for immune support, respiratory infections, allergy symptoms, cardiovascular health, exercise recovery and healthy aging. The evidence does not support treating these as one claim. A null respiratory outcome says nothing direct about blood pressure; a short safety study says nothing about senolytic efficacy; a laboratory mast-cell result is not a clinical allergy trial.

For exercise performance, NIH ODS concludes that numerous small, short trials show little to no effect on endurance capacity or maximal oxygen consumption. Evidence for recovery outcomes uses different populations and endpoints and should not be generalized to performance. [1]

Which form and label details matter?

Record the exact chemical form, ingredient source, delivery system, milligrams per administration, number of administrations, whether it is a single ingredient, and the lot. Phospholipid complexes and glycosylated forms can change exposure. A higher blood concentration is a pharmacokinetic result, not proof of a better clinical outcome.

Combination products often add vitamin C, bromelain, zinc or other flavonoids. Results from those mixtures cannot isolate quercetin. Dietary intake from whole foods also differs from concentrated supplement exposure.

What does the human evidence show?

Heinz 2010 randomized 1002 adults aged 18 to 85 years to placebo or a combination supplying 500 or 1000 mg/day each of quercetin and vitamin C plus 20 or 40 mg/day niacin as nicotinamide for 12 weeks. Participants took two soft chews on awakening and two between 14:00 and the last meal and recorded symptoms daily. The full cohort showed no significant group difference in upper-respiratory infection rate, sick days or symptom severity. A separate analysis of 325 participants age 40 years or older who rated themselves in the fitter half found lower severity and sick days in the higher-dose combination group. That subgroup is hypothesis-generating because the principal comparison was null, and the combination design prevents attribution to quercetin alone. [2]

Edwards 2007 used a randomized, double-blind, placebo-controlled crossover design. Quercetin 730 mg/day for 28 days did not change blood pressure in 19 participants with prehypertension. Among 22 participants with stage 1 hypertension, systolic, diastolic and mean arterial pressures decreased. Oxidative-stress markers did not change. The small subgroup and short duration limit generalization and do not establish cardiovascular-event benefit. [3]

Han 2020 randomized nine people with COPD across three dose cohorts. Two participants in each cohort received 500, 1000 or 2000 mg/day and one received placebo, divided twice daily with food for seven days. No study-drug-related severe adverse event was detected, but a nine-person, one-week study cannot exclude uncommon harms or establish long-term safety. [4]

NIH ODS describes mixed results from the few respiratory-infection trials and limited evidence for COVID-19. It should not be used as a replacement for vaccination, testing, antiviral treatment when indicated or clinical assessment of breathing difficulty. [1]

How might quercetin work?

Quercetin and its metabolites can affect redox reactions, inflammatory signaling, platelet function and drug-metabolizing enzymes in laboratory systems. After ingestion, quercetin undergoes extensive intestinal and hepatic metabolism; circulating compounds are largely conjugated metabolites rather than unchanged aglycone. Concentrations used in cell studies may not match human tissue exposure.

An absorption-enhancing formulation may raise measured plasma exposure. It still requires its own clinical outcome evidence. Mechanism, absorption and clinical benefit are three separate questions.

What are the risks and interactions?

Short studies report gastrointestinal symptoms such as abdominal discomfort, reflux, constipation or diarrhea. NIH ODS notes no serious adverse effects in trials using up to 1000 mg/day for up to 12 weeks, but Andres 2018 found adequate safety data unavailable for high supplemental doses at or above 1000 mg/day beyond 12 weeks. [1], [5]

Review quercetin with a pharmacist or clinician if you take anticoagulants, antiplatelet drugs, blood-pressure medicine, cyclosporine or other narrow-therapeutic-index drugs, pravastatin, fexofenadine, or cancer therapy. Some interaction concerns come from laboratory or animal studies, while a warfarin interaction has been reported in a case; these levels of evidence should not be presented as equal. [1], [7]

Pregnancy and breastfeeding data are inadequate. The cited Canadian product record instructs consumers not to use that product during pregnancy or breastfeeding. Kidney disease, planned surgery and treatment requiring stable drug concentrations also warrant review. [5], [6]

Get urgent care for trouble breathing, facial or throat swelling, fainting, severe weakness, uncontrolled bleeding, black or bloody stool, chest pain or stroke symptoms.

Legal status in the United States and Canada

In the United States, quercetin may be sold as a dietary supplement. FDA premarket approval of efficacy is not required for supplements. GRAS food-ingredient notices concern specified food uses and do not establish that a supplement treats disease. [1]

In Canada, licensed natural health products carry an eight-digit NPN. NPN 80007930 is an example of a product-specific record for 500 mg capsules used twice daily. Its licence cannot be transferred to every quercetin formulation. [6]

What should be monitored?

Record chemical form, delivery system, amount per administration, frequency, start and stop dates, target outcome, blood pressure when relevant, respiratory symptoms, gastrointestinal effects, bruising or bleeding, sleep changes and all medicines. Note changes one at a time when clinically appropriate.

What happens after stopping?

No withdrawal syndrome or evidence-based taper is established. Symptoms or blood pressure may follow their underlying course. Do not change prescribed medicines based on supplement tracking alone.

How should quercetin be stored?

Follow the label and keep the product sealed away from heat, light and moisture. Retain the ingredient panel, lot and expiry date because formulation is central to interpretation.

Community experience

Community reports often describe allergy relief, fewer colds or exercise recovery. They rarely control for formulation, season, exposure, vaccination, concurrent ingredients or regression to the mean. Reports can surface tolerability questions, but they cannot establish efficacy or comparative absorption.

How does quercetin compare with other approaches?

Quercetin is not a substitute for vaccination, evidence-based infection treatment, prescribed blood-pressure therapy or urgent allergy care. Food sources provide quercetin within a broader dietary pattern and at different exposure than concentrated supplements. Comparing products requires form and actual clinical outcome data, not only claims of higher absorption.

Common questions

Did 1000 mg/day prevent respiratory infections?

Not in the full 1002-person cohort over 12 weeks. The favorable result came from a post hoc fitter, older subgroup. [2]

Does quercetin lower blood pressure?

A small crossover trial found a short-term reduction in stage 1 hypertension but no effect in prehypertension. That does not establish long-term benefit or replace treatment. [3]

Are phytosome and aglycone doses equivalent?

No. Delivery systems may alter exposure, and milligram amounts cannot be converted into clinical equivalence without direct data.

Is quercetin a proven allergy treatment?

No. Laboratory histamine and mast-cell findings have not established clinical efficacy for allergic disease. [7]

Is 2000 mg/day proven safe?

No. The cited exposure was tested for seven days in only six treated COPD participants across dose cohorts. [4]

Can quercetin interact with medicines?

Yes, or plausibly so. Interaction evidence ranges from laboratory findings to a warfarin case report; medication review is appropriate. [1], [7]

Is it safe in pregnancy?

Safety is inadequately established. The cited Canadian product record advises against use during pregnancy or breastfeeding. [6]

Glossary

Terms used in this guide.

Flavonol

A subclass of plant polyphenols that includes quercetin.

Aglycone

A compound without an attached sugar group; one common supplemental quercetin form.

Glycoside

A molecule bound to a sugar group, which can affect absorption and metabolism.

Pharmacokinetics

How the body absorbs, distributes, metabolizes and removes a substance.

Post hoc subgroup

An analysis defined or emphasized after examining trial data; useful for hypotheses but more prone to chance findings.

Titration

Planned dose adjustment; no self-titration schedule is established here.

How this guide was researched

This draft prioritized current NIH ODS and MSKCC summaries, live NCBI records, the full Han 2020 primary article and a current Health Canada product record. Evidence was refreshed October 9, 2026.

How this guide was made

The ledger preserves formulation, population, comparator, exact regimen, access scope, primary versus subgroup results and short-term safety limits.

Sources

Related guides